Singapore markets open in 4 hours 17 minutes

BioLineRx Ltd. (BLRX.TA)

Tel Aviv - Tel Aviv Delayed price. Currency in ILA (0.01 ILS)
Add to watchlist
19.00+0.70 (+3.83%)
At close: 05:24PM IDT
Currency in ILA

Valuation measures4

Market cap (intra-day) 219.43M
Enterprise value 156.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.59
Price/book (mrq)4.52
Enterprise value/revenue 3.61
Enterprise value/EBITDA 1.66

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 3-54.36%
S&P500 52-week change 323.49%
52-week high 370.00
52-week low 315.10
50-day moving average 319.99
200-day moving average 333.70

Share statistics

Avg vol (3-month) 31.56M
Avg vol (10-day) 3948.73k
Shares outstanding 51.2B
Implied shares outstanding 61.2B
Float 8989.89M
% held by insiders 10.36%
% held by institutions 10.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 Jun 2015

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-247.15%

Management effectiveness

Return on assets (ttm)-38.30%
Return on equity (ttm)-189.23%

Income statement

Revenue (ttm)4.8M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -42.17M
Net income avi to common (ttm)-60.61M
Diluted EPS (ttm)-0.19
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)42.99M
Total cash per share (mrq)0.04
Total debt (mrq)11.59M
Total debt/equity (mrq)87.66%
Current ratio (mrq)1.53
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-22.61M
Levered free cash flow (ttm)-9.6M